Get the Stockscreener App
14.60
3.40%
0.48
After Hours:
14.89
0.29
+1.99%
Clearpoint Neuro Inc stock is traded at $14.60, with a volume of 324.43K.
It is up +3.40% in the last 24 hours and down -21.00% over the past month.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
See More
Previous Close:
$14.12
Open:
$14.16
24h Volume:
324.43K
Relative Volume:
0.47
Market Cap:
$437.85M
Revenue:
$40.61M
Net Income/Loss:
$-29.07M
P/E Ratio:
-14.48
EPS:
-1.0081
Net Cash Flow:
$-26.70M
1W Performance:
-2.99%
1M Performance:
-21.00%
6M Performance:
+1.46%
1Y Performance:
+30.01%
1-Day Range:
$14.16
$14.86
1-Week Range:
$13.93
$15.53
52-Week Range:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.60 | 423.45M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.813|Chg%:+0.693 - TradingKey
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearpoint Neuro Inc (CLPT) Balance Sheet - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.120|Chg%:-0.370 - TradingKey
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
ClearPoint Neuro to announce Q2 2026 results on August 3 - scanx.trade
Articles from ClearPoint Neuro, Inc. - FinancialContent
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026 - ACCESS Newswire
ClearPoint Neuro Q2 review starts Aug. 3 at 4:30 p.m. ET - Stock Titan
ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings: EPS Misses Estimates, Stock Declines Over 3%Margin Expansion Trends - dars.gov.et
EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery - Contract Pharma
ClearPoint Neuro Slips Over 3% as Shares Test Key Support LevelsWave Equality - dars.gov.et
Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DipRevenue Surprise History - dars.gov.et
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Form 4 Clearpoint Neuro Inc For: 6 July By Investing.com - Investing.com Canada
Director at ClearPoint Neuro (NASDAQ: CLPT) receives 222-share stock grant - Stock Titan
ClearPoint Neuro (CLPT) Holds Steady Near $18.72 as Traders Eye Key Support and Resistance LevelsLong Term Entry Picks - dars.gov.et
CLPTClearPoint Neuro Inc Volatility & Greeks - Finviz
ClearPoint Neuro outlines growth ambitions in precision neurosurgery - Ad-hoc-news.de
Form 4 Clearpoint Neuro Inc For: 2 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CBO adds 1,781 ESPP shares, now holds 110,263 - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY - Moomoo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo - Moomoo
ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH - Moomoo
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing - marketscreener.com
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Nigeria
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
ClearPoint Neuro | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):